FEATURED NEWS

FDA
December 12, 2018
FDA approves TEMIXYS: New HIV Fixed Dose Drug Combination November 27, 2018: FDA recently approved TEMIXYS (lamivudine and tenofovir disoproxil fumarate) tablets, indicated for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adult and pediatric patients weighing at least 35 kg. TEMIXYS was approved based on two MORE
MATEC
December 12, 2018
GENVOYA renal labeling updates Click here to view full announcement with additional information (webpage) VIREAD HBV label updates (pediatrics) Click here to view full announcement with additional information (website)
MATEC
December 10, 2018
www.matec.info HIV News Alert Updated HHS Perinatal Antiretroviral Treatment Guidelines Released December 7, 2018: The HHS Panel on Treatment of Pregnant Women with HIV Infection and Prevention of Perinatal Transmission (the Panel) is pleased to announce the release of the updated Recommendations for the Use of Antiretroviral Drugs in Pregnant MORE
MATEC
November 27, 2018
OHIO: Increased HIV Transmission through Injection Drug Use The Ohio Department of Health (ODH) is observing an increase in newly diagnosed HIV infections being reported among persons who inject drugs (PWID). While HIV remains predominantly a sexually transmitted infection, the proportion of cases reporting injection drug use (IDU) as the mode of MORE
MATEC
March 9, 2018
Updates to the Human Papillomavirus Disease Section of the Adult and Adolescent Oppotunistic Infections Guidelines Last updated: March 7, 2018; Last Reviewed: March 7, 2018 The Human Papillomavirus Disease section of the Guidlines for the Prevention and Treatment of Opportunistic Infections in HIV-infected Adults and adolescents was updated on March MORE
MATEC
October 20, 2017
Perinatal Antiretroviral Treatment Guidelines Updated October 19, 2017: The Recommendations for the use of Antiretroviral Drugs in Pregnant Women with HIV Infection and Interventions to Reduce Perinatal HIV Transmission in the United States were recently updated. The following is a summary of what's changed in this revision: Recommendations for Use of MORE
MATEC
October 20, 2017
HHS Adult and Adolescent Antiretroviral Treatment Guidelines Updated The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (the Panel) has released an updated version of the Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents Living with HIV Key guideline updates include the following: In the What to Start MORE
FDA
October 13, 2017
FDA Approved changes to the Sustiva label, Genvoya, Norvir, Descovy and more. On October 12, 2017 the FDA approved changed to the Sustiva (efavienz) package insert to: Update information on hepatotoxicity in DOSAGE and ADMINISTRATION, WARNINGS AND PRECAUTIONS, ADVERSEREACTIONS and Patient Information sections. Update CONTRAINDICATIONS and MORE
MATEC
August 17, 2017
Adult and Adolescent Opportunistic Infections Guidlines Updated The following sections of the Guidelines for the Prevemtion and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently been updated: Hepatitis B Virus infection: This section was updated to include TAF/FTC as a treatment option for patients with HBV/HIV MORE
MATEC
August 1, 2017
Adult and Adolescent Opportunistic Infections Guidelines Updated July 28, 2017: The following sections of the Guidlines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents have recently been updated: Click here to view recently updated guidlines Sections of the Pneumocystis guidlines have been MORE
FDA
June 21, 2017
FDA approves changes to the Kaletra label FDA approved changes to the Kaletra (lopinavir/ritonavir) tablet and oral solution labels. These changes include updates to the following sections: Section 2: DOSAGE and ADMINISTRATION with information about use of the oral solution with a feeding tube. 2.1 General Administration Recommendations Because MORE
MATEC
June 1, 2017
Updates to the Tuberculosis Section of the Adult and Adolescent Opportunistic Infections Guidelines May 18, 2017: The tuberculosis (TB) section of the Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents was recently updated. In this revision, the epidemiology, diagnosis, and treatment sections MORE

Pages